These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 22748405)
1. Clinical impact of peripheral attacks in hereditary angioedema patients. Kusuma A; Relan A; Knulst AC; Moldovan D; Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Hack CE Am J Med; 2012 Sep; 125(9):937.e17-24. PubMed ID: 22748405 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial. Riedl MA; Bernstein JA; Li H; Reshef A; Lumry W; Moldovan D; Farkas H; Levy R; Baker J; Hardiman Y; Totoritis MC; Relan A; Cicardi M; Ann Allergy Asthma Immunol; 2014 Feb; 112(2):163-169.e1. PubMed ID: 24468257 [TBL] [Abstract][Full Text] [Related]
3. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks. Li HH; Moldovan D; Bernstein JA; Reshef A; Porebski G; Stobiecki M; Baker J; Levy R; Relan A; Riedl M J Allergy Clin Immunol Pract; 2015; 3(3):417-23. PubMed ID: 25680925 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study. Riedl MA; Levy RJ; Suez D; Lockey RF; Baker JW; Relan A; Zuraw BL Ann Allergy Asthma Immunol; 2013 Apr; 110(4):295-9. PubMed ID: 23535096 [TBL] [Abstract][Full Text] [Related]
5. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. Zuraw B; Cicardi M; Levy RJ; Nuijens JH; Relan A; Visscher S; Haase G; Kaufman L; Hack CE J Allergy Clin Immunol; 2010 Oct; 126(4):821-827.e14. PubMed ID: 20920772 [TBL] [Abstract][Full Text] [Related]
6. Use of recombinant C1 inhibitor in patients with resistant or frequent attacks of hereditary or acquired angioedema. Manson AL; Dempster J; Grigoriadou S; Buckland MS; Longhurst HJ Eur J Dermatol; 2014; 24(1):28-34. PubMed ID: 24556385 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema. Zuraw BL; Kalfus I Am J Med; 2012 Sep; 125(9):938.e1-7. PubMed ID: 22800873 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078 [TBL] [Abstract][Full Text] [Related]
10. rhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiency. Varga L; Farkas H Expert Rev Clin Immunol; 2011 Mar; 7(2):143-53. PubMed ID: 21426252 [TBL] [Abstract][Full Text] [Related]
11. Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency. Bork K Expert Rev Clin Immunol; 2011 Nov; 7(6):723-33. PubMed ID: 22014012 [TBL] [Abstract][Full Text] [Related]
12. Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview study. McMillan CV; Speight J; Relan A; Bellizzi L; Haase G; Cicardi M Patient; 2012; 5(2):113-26. PubMed ID: 22462765 [TBL] [Abstract][Full Text] [Related]
13. A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema. van Doorn MB; Burggraaf J; van Dam T; Eerenberg A; Levi M; Hack CE; Schoemaker RC; Cohen AF; Nuijens J J Allergy Clin Immunol; 2005 Oct; 116(4):876-83. PubMed ID: 16210064 [TBL] [Abstract][Full Text] [Related]
14. Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Lumry WR; Li HH; Levy RJ; Potter PC; Farkas H; Moldovan D; Riedl M; Li H; Craig T; Bloom BJ; Reshef A Ann Allergy Asthma Immunol; 2011 Dec; 107(6):529-37. PubMed ID: 22123383 [TBL] [Abstract][Full Text] [Related]
16. Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk. Reshef A; Zanichelli A; Longhurst H; Relan A; Hack CE Allergy; 2015 May; 70(5):506-13. PubMed ID: 25640891 [TBL] [Abstract][Full Text] [Related]
17. Hereditary Angioedema Attacks: Local Swelling at Multiple Sites. Hofman ZL; Relan A; Hack CE Clin Rev Allergy Immunol; 2016 Feb; 50(1):34-40. PubMed ID: 25527240 [TBL] [Abstract][Full Text] [Related]
18. Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study. Reshef A; Moldovan D; Obtulowicz K; Leibovich I; Mihaly E; Visscher S; Relan A Allergy; 2013 Jan; 68(1):118-24. PubMed ID: 23121116 [TBL] [Abstract][Full Text] [Related]
19. A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family. Ferraro MF; Moreno AS; Castelli EC; Donadi EA; Palma MS; Arcuri HA; Lange AP; Bork K; Sarti W; Arruda LK Allergy; 2011 Oct; 66(10):1384-90. PubMed ID: 21623829 [TBL] [Abstract][Full Text] [Related]
20. Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks. Bernstein JA; Relan A; Harper JR; Riedl M Ann Allergy Asthma Immunol; 2017 Apr; 118(4):452-455. PubMed ID: 28284978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]